Compile Data Set for Download or QSAR
Report error Found 72 Enz. Inhib. hit(s) with all data for entry = 50027853
TargetCannabinoid receptor 2(Human)
Amgen

Curated by ChEMBL
LigandPNGBDBM50254066(1-(phenylsulfonyl)-N-(quinolin-3-yl)cyclopropaneca...)
Affinity DataEC50:  4nMAssay Description:Agonist activity at human CB2 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetCannabinoid receptor 2(Human)
Amgen

Curated by ChEMBL
LigandPNGBDBM50254143(N-(4-chloro-3-(furan-2-yl)phenyl)-2-(4-chloropheny...)
Affinity DataEC50:  4nMAssay Description:Agonist activity at human CB2 receptor expressed in SF9 cells assessed as inhibition of CP-55940-stimulated GTP bindingMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetCannabinoid receptor 2(Human)
Amgen

Curated by ChEMBL
LigandPNGBDBM50254104(N-(4-chloro-3-(trifluoromethyl)phenyl)-2-(4-chloro...)
Affinity DataEC50:  5nMAssay Description:Agonist activity at human CB2 receptor expressed in CHO cells assessed as suppression of forskolin-stimulated cAMP accumulationMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetCannabinoid receptor 2(Human)
Amgen

Curated by ChEMBL
LigandPNGBDBM50254143(N-(4-chloro-3-(furan-2-yl)phenyl)-2-(4-chloropheny...)
Affinity DataEC50:  5nMAssay Description:Agonist activity at human CB2 receptor expressed in CHO cells assessed as suppression of forskolin-stimulated cAMP accumulationMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetCannabinoid receptor 2(Human)
Amgen

Curated by ChEMBL
LigandPNGBDBM50254144(2-(4-chlorophenylsulfonyl)-2-methyl-N-(5-(5-methyl...)
Affinity DataEC50:  5nMAssay Description:Agonist activity at human CB2 receptor expressed in CHO cells assessed as suppression of forskolin-stimulated cAMP accumulationMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetCannabinoid receptor 2(Human)
Amgen

Curated by ChEMBL
LigandPNGBDBM50254067(2-methyl-N-(quinolin-3-yl)-2-(4-(trifluoromethyl)p...)
Affinity DataEC50:  8nMAssay Description:Agonist activity at human CB2 receptor expressed in CHO cells assessed as suppression of forskolin-stimulated cAMP accumulationMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetCannabinoid receptor 2(Human)
Amgen

Curated by ChEMBL
LigandPNGBDBM50254045(N-(9-ethyl-9H-carbazol-3-yl)-1-(phenylsulfonyl)cyc...)
Affinity DataEC50:  8nMAssay Description:Agonist activity at human CB2 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetCannabinoid receptor 2(Human)
Amgen

Curated by ChEMBL
LigandPNGBDBM50254144(2-(4-chlorophenylsulfonyl)-2-methyl-N-(5-(5-methyl...)
Affinity DataEC50:  9nMAssay Description:Agonist activity at human CB2 receptor expressed in SF9 cells assessed as inhibition of CP-55940-stimulated GTP bindingMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetCannabinoid receptor 2(Human)
Amgen

Curated by ChEMBL
LigandPNGBDBM50254161(N-(5-tert-butylisoxazol-3-yl)-2-(4-chlorophenylsul...)
Affinity DataEC50:  11nMAssay Description:Agonist activity at human CB2 receptor expressed in CHO cells assessed as suppression of forskolin-stimulated cAMP accumulationMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetCannabinoid receptor 2(Human)
Amgen

Curated by ChEMBL
LigandPNGBDBM50254101(2-(4-chlorophenylsulfonyl)-2-methyl-N-(quinolin-3-...)
Affinity DataEC50:  13nMAssay Description:Agonist activity at human CB2 receptor expressed in CHO cells assessed as suppression of forskolin-stimulated cAMP accumulationMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetCannabinoid receptor 2(Human)
Amgen

Curated by ChEMBL
LigandPNGBDBM50254068(2-(2-chloro-4-(trifluoromethyl)phenylsulfonyl)-2-m...)
Affinity DataEC50:  19nMAssay Description:Agonist activity at human CB2 receptor expressed in SF9 cells assessed as inhibition of CP-55940-stimulated GTP bindingMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetCannabinoid receptor 2(Human)
Amgen

Curated by ChEMBL
LigandPNGBDBM50254104(N-(4-chloro-3-(trifluoromethyl)phenyl)-2-(4-chloro...)
Affinity DataEC50:  20nMAssay Description:Agonist activity at human CB2 receptor expressed in SF9 cells assessed as inhibition of CP-55940-stimulated GTP bindingMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetCannabinoid receptor 2(Human)
Amgen

Curated by ChEMBL
LigandPNGBDBM50254147(N-(3-tert-butyl-1-methyl-1H-pyrazol-5-yl)-2-(4-chl...)
Affinity DataEC50:  25nMAssay Description:Agonist activity at human CB2 receptor expressed in CHO cells assessed as suppression of forskolin-stimulated cAMP accumulationMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetCannabinoid receptor 2(Human)
Amgen

Curated by ChEMBL
LigandPNGBDBM50254147(N-(3-tert-butyl-1-methyl-1H-pyrazol-5-yl)-2-(4-chl...)
Affinity DataEC50:  26nMAssay Description:Agonist activity at human CB2 receptor expressed in SF9 cells assessed as inhibition of CP-55940-stimulated GTP bindingMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetCannabinoid receptor 2(Human)
Amgen

Curated by ChEMBL
LigandPNGBDBM50254161(N-(5-tert-butylisoxazol-3-yl)-2-(4-chlorophenylsul...)
Affinity DataEC50:  29nMAssay Description:Agonist activity at human CB2 receptor expressed in SF9 cells assessed as inhibition of CP-55940-stimulated GTP bindingMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetCannabinoid receptor 2(Human)
Amgen

Curated by ChEMBL
LigandPNGBDBM50254100(2-(4-fluorophenylsulfonyl)-2-methyl-N-(quinolin-3-...)
Affinity DataEC50:  33nMAssay Description:Agonist activity at human CB2 receptor expressed in CHO cells assessed as suppression of forskolin-stimulated cAMP accumulationMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetCannabinoid receptor 2(Human)
Amgen

Curated by ChEMBL
LigandPNGBDBM50254102(2-(4-chlorophenylsulfonyl)-2-methyl-N-(3-(trifluor...)
Affinity DataEC50:  35nMAssay Description:Agonist activity at human CB2 receptor expressed in CHO cells assessed as suppression of forskolin-stimulated cAMP accumulationMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetCannabinoid receptor 2(Human)
Amgen

Curated by ChEMBL
LigandPNGBDBM50254103(2-(4-chlorophenylsulfonyl)-2-methyl-N-(4-(trifluor...)
Affinity DataEC50:  57nMAssay Description:Agonist activity at human CB2 receptor expressed in CHO cells assessed as suppression of forskolin-stimulated cAMP accumulationMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetCannabinoid receptor 2(Human)
Amgen

Curated by ChEMBL
LigandPNGBDBM50254101(2-(4-chlorophenylsulfonyl)-2-methyl-N-(quinolin-3-...)
Affinity DataEC50:  57nMAssay Description:Agonist activity at human CB2 receptor expressed in SF9 cells assessed as inhibition of CP-55940-stimulated GTP bindingMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetCannabinoid receptor 2(Human)
Amgen

Curated by ChEMBL
LigandPNGBDBM50254068(2-(2-chloro-4-(trifluoromethyl)phenylsulfonyl)-2-m...)
Affinity DataEC50:  73nMAssay Description:Agonist activity at human CB2 receptor expressed in CHO cells assessed as suppression of forskolin-stimulated cAMP accumulationMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetCannabinoid receptor 1(Human)
Amgen

Curated by ChEMBL
LigandPNGBDBM50254067(2-methyl-N-(quinolin-3-yl)-2-(4-(trifluoromethyl)p...)
Affinity DataEC50:  82nMAssay Description:Agonist activity at human CB1 receptor expressed in CHO cells assessed as suppression of forskolin-stimulated cAMP accumulationMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetCannabinoid receptor 2(Human)
Amgen

Curated by ChEMBL
LigandPNGBDBM50254125(N-(3-bromo-4-chlorophenyl)-2-(4-chlorophenylsulfon...)
Affinity DataEC50:  86nMAssay Description:Agonist activity at human CB2 receptor expressed in SF9 cells assessed as inhibition of CP-55940-stimulated GTP bindingMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetCannabinoid receptor 2(Human)
Amgen

Curated by ChEMBL
LigandPNGBDBM50254067(2-methyl-N-(quinolin-3-yl)-2-(4-(trifluoromethyl)p...)
Affinity DataEC50:  96nMAssay Description:Agonist activity at human CB2 receptor expressed in SF9 cells assessed as inhibition of CP-55940-stimulated GTP bindingMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetCannabinoid receptor 1(Human)
Amgen

Curated by ChEMBL
LigandPNGBDBM50254143(N-(4-chloro-3-(furan-2-yl)phenyl)-2-(4-chloropheny...)
Affinity DataEC50:  96nMAssay Description:Agonist activity at human CB1 receptor expressed in SF9 cells assessed as inhibition of CP-55940-stimulated GTP bindingMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetCannabinoid receptor 2(Human)
Amgen

Curated by ChEMBL
LigandPNGBDBM50254069(2-(2-chloro-4-fluorophenylsulfonyl)-2-methyl-N-(qu...)
Affinity DataEC50:  104nMAssay Description:Agonist activity at human CB2 receptor expressed in SF9 cells assessed as inhibition of CP-55940-stimulated GTP bindingMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetCannabinoid receptor 2(Human)
Amgen

Curated by ChEMBL
LigandPNGBDBM50254100(2-(4-fluorophenylsulfonyl)-2-methyl-N-(quinolin-3-...)
Affinity DataEC50:  109nMAssay Description:Agonist activity at human CB2 receptor expressed in SF9 cells assessed as inhibition of CP-55940-stimulated GTP bindingMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetCannabinoid receptor 2(Human)
Amgen

Curated by ChEMBL
LigandPNGBDBM50254044(N-(9-ethyl-9H-carbazol-3-yl)-3-(3-(2-fluorophenyl)...)
Affinity DataEC50:  111nMAssay Description:Agonist activity at human CB2 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetCannabinoid receptor 2(Human)
Amgen

Curated by ChEMBL
LigandPNGBDBM50254103(2-(4-chlorophenylsulfonyl)-2-methyl-N-(4-(trifluor...)
Affinity DataEC50:  115nMAssay Description:Agonist activity at human CB2 receptor expressed in SF9 cells assessed as inhibition of CP-55940-stimulated GTP bindingMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetCannabinoid receptor 2(Human)
Amgen

Curated by ChEMBL
LigandPNGBDBM50254070(2-(2-chloro-4-methoxyphenylsulfonyl)-2-methyl-N-(q...)
Affinity DataEC50:  148nMAssay Description:Agonist activity at human CB2 receptor expressed in SF9 cells assessed as inhibition of CP-55940-stimulated GTP bindingMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetCannabinoid receptor 2(Human)
Amgen

Curated by ChEMBL
LigandPNGBDBM50254102(2-(4-chlorophenylsulfonyl)-2-methyl-N-(3-(trifluor...)
Affinity DataEC50:  170nMAssay Description:Agonist activity at human CB2 receptor expressed in SF9 cells assessed as inhibition of CP-55940-stimulated GTP bindingMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetCannabinoid receptor 2(Human)
Amgen

Curated by ChEMBL
LigandPNGBDBM50254163(2-(4-chlorophenylsulfonyl)-2-methyl-N-(5-o-tolyl-1...)
Affinity DataEC50:  189nMAssay Description:Agonist activity at human CB2 receptor expressed in SF9 cells assessed as inhibition of CP-55940-stimulated GTP bindingMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetCannabinoid receptor 2(Human)
Amgen

Curated by ChEMBL
LigandPNGBDBM50254162(2-(4-chlorophenylsulfonyl)-2-methyl-N-(5-(3-methyl...)
Affinity DataEC50:  216nMAssay Description:Agonist activity at human CB2 receptor expressed in SF9 cells assessed as inhibition of CP-55940-stimulated GTP bindingMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetCannabinoid receptor 1(Human)
Amgen

Curated by ChEMBL
LigandPNGBDBM50254143(N-(4-chloro-3-(furan-2-yl)phenyl)-2-(4-chloropheny...)
Affinity DataEC50:  230nMAssay Description:Agonist activity at human CB1 receptor expressed in CHO cells assessed as suppression of forskolin-stimulated cAMP accumulationMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetCannabinoid receptor 1(Human)
Amgen

Curated by ChEMBL
LigandPNGBDBM50254144(2-(4-chlorophenylsulfonyl)-2-methyl-N-(5-(5-methyl...)
Affinity DataEC50:  322nMAssay Description:Agonist activity at human CB1 receptor expressed in SF9 cells assessed as inhibition of CP-55940-stimulated GTP bindingMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetCannabinoid receptor 1(Human)
Amgen

Curated by ChEMBL
LigandPNGBDBM50254144(2-(4-chlorophenylsulfonyl)-2-methyl-N-(5-(5-methyl...)
Affinity DataEC50:  331nMAssay Description:Agonist activity at human CB1 receptor expressed in CHO cells assessed as suppression of forskolin-stimulated cAMP accumulationMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetCannabinoid receptor 1(Human)
Amgen

Curated by ChEMBL
LigandPNGBDBM50254045(N-(9-ethyl-9H-carbazol-3-yl)-1-(phenylsulfonyl)cyc...)
Affinity DataEC50:  390nMAssay Description:Agonist activity at human CB1 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetCannabinoid receptor 1(Human)
Amgen

Curated by ChEMBL
LigandPNGBDBM50254067(2-methyl-N-(quinolin-3-yl)-2-(4-(trifluoromethyl)p...)
Affinity DataEC50:  710nMAssay Description:Agonist activity at human CB1 receptor expressed in SF9 cells assessed as inhibition of CP-55940-stimulated GTP bindingMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetCannabinoid receptor 1(Human)
Amgen

Curated by ChEMBL
LigandPNGBDBM50254102(2-(4-chlorophenylsulfonyl)-2-methyl-N-(3-(trifluor...)
Affinity DataEC50: >1.00E+3nMAssay Description:Agonist activity at human CB1 receptor expressed in CHO cells assessed as suppression of forskolin-stimulated cAMP accumulationMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetCannabinoid receptor 1(Human)
Amgen

Curated by ChEMBL
LigandPNGBDBM50254103(2-(4-chlorophenylsulfonyl)-2-methyl-N-(4-(trifluor...)
Affinity DataEC50: >1.00E+3nMAssay Description:Agonist activity at human CB1 receptor expressed in CHO cells assessed as suppression of forskolin-stimulated cAMP accumulationMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetCannabinoid receptor 1(Human)
Amgen

Curated by ChEMBL
LigandPNGBDBM50254101(2-(4-chlorophenylsulfonyl)-2-methyl-N-(quinolin-3-...)
Affinity DataEC50: >1.00E+3nMAssay Description:Agonist activity at human CB1 receptor expressed in CHO cells assessed as suppression of forskolin-stimulated cAMP accumulationMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetCannabinoid receptor 2(Human)
Amgen

Curated by ChEMBL
LigandPNGBDBM50254129(N-(3-chloro-4-fluorobenzyl)-2-(4-chlorophenylsulfo...)
Affinity DataEC50:  1.30E+3nMAssay Description:Agonist activity at human CB2 receptor expressed in SF9 cells assessed as inhibition of CP-55940-stimulated GTP bindingMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetCannabinoid receptor 1(Human)
Amgen

Curated by ChEMBL
LigandPNGBDBM50254068(2-(2-chloro-4-(trifluoromethyl)phenylsulfonyl)-2-m...)
Affinity DataEC50:  1.57E+3nMAssay Description:Agonist activity at human CB1 receptor expressed in SF9 cells assessed as inhibition of CP-55940-stimulated GTP bindingMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetCannabinoid receptor 2(Human)
Amgen

Curated by ChEMBL
LigandPNGBDBM50254126(N-(4-chloro-2-(trifluoromethoxy)phenyl)-2-(4-chlor...)
Affinity DataEC50:  1.62E+3nMAssay Description:Agonist activity at human CB2 receptor expressed in SF9 cells assessed as inhibition of CP-55940-stimulated GTP bindingMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetCannabinoid receptor 1(Human)
Amgen

Curated by ChEMBL
LigandPNGBDBM50254163(2-(4-chlorophenylsulfonyl)-2-methyl-N-(5-o-tolyl-1...)
Affinity DataEC50:  1.65E+3nMAssay Description:Agonist activity at human CB1 receptor expressed in SF9 cells assessed as inhibition of CP-55940-stimulated GTP bindingMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetCannabinoid receptor 1(Human)
Amgen

Curated by ChEMBL
LigandPNGBDBM50254101(2-(4-chlorophenylsulfonyl)-2-methyl-N-(quinolin-3-...)
Affinity DataEC50:  1.68E+3nMAssay Description:Agonist activity at human CB1 receptor expressed in SF9 cells assessed as inhibition of CP-55940-stimulated GTP bindingMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetCannabinoid receptor 1(Human)
Amgen

Curated by ChEMBL
LigandPNGBDBM50254161(N-(5-tert-butylisoxazol-3-yl)-2-(4-chlorophenylsul...)
Affinity DataEC50:  1.92E+3nMAssay Description:Agonist activity at human CB1 receptor expressed in SF9 cells assessed as inhibition of CP-55940-stimulated GTP bindingMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetCannabinoid receptor 1(Human)
Amgen

Curated by ChEMBL
LigandPNGBDBM50254068(2-(2-chloro-4-(trifluoromethyl)phenylsulfonyl)-2-m...)
Affinity DataEC50: >2.00E+3nMAssay Description:Agonist activity at human CB1 receptor expressed in CHO cells assessed as suppression of forskolin-stimulated cAMP accumulationMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetCannabinoid receptor 1(Human)
Amgen

Curated by ChEMBL
LigandPNGBDBM50254044(N-(9-ethyl-9H-carbazol-3-yl)-3-(3-(2-fluorophenyl)...)
Affinity DataEC50: >2.00E+3nMAssay Description:Agonist activity at human CB1 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetCannabinoid receptor 1(Human)
Amgen

Curated by ChEMBL
LigandPNGBDBM50254161(N-(5-tert-butylisoxazol-3-yl)-2-(4-chlorophenylsul...)
Affinity DataEC50: >2.00E+3nMAssay Description:Agonist activity at human CB1 receptor expressed in CHO cells assessed as suppression of forskolin-stimulated cAMP accumulationMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetCannabinoid receptor 1(Human)
Amgen

Curated by ChEMBL
LigandPNGBDBM50254147(N-(3-tert-butyl-1-methyl-1H-pyrazol-5-yl)-2-(4-chl...)
Affinity DataEC50: >2.00E+3nMAssay Description:Agonist activity at human CB1 receptor expressed in CHO cells assessed as suppression of forskolin-stimulated cAMP accumulationMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
Displayed 1 to 50 (of 72 total ) | Next | Last >>
Jump to: